A pair of biotechs prepares to hit Nasdaq, as total 2021 IPO raise quickly approaches $3B
After a busy week last week when 10 biotechs went public, the industry continues to see a steady stream of companies making their debuts. …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
